Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Parra

Showing results (241-250 of 292) with videos related to

Pageof 30
Sort By:
Histopathology|December 17, 2008
Annexin A1 subcellular expression in laryngeal squamous cell carcinomaV A F Alves, S Nonogaki, P M Cury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLCPedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune functionM Choi, H Kadara, J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2018
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-upH Kadara, M Choi, J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-upH Kadara, M Choi, J Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2020
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to PembrolizumabEmily Z Keung, Melissa Burgess, Ruth Salazar, et al.
Vox Sanguinis|November 25, 2003
Current status of immunoprophylaxis with anti-D immunoglobinC P Engelfriet, H W Reesink, W J Judd, et al.
Nature Communications|May 10, 2023
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinomaJose A Karam, Pavlos Msaouel, Cara L Haymaker, et al.
Med (New York, N.Y.)|August 16, 2024
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trialJeffrey A How, Minghao Dang, Sanghoon Lee, et al.
Journal of Cutaneous Pathology|May 7, 2023
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T<sub>H</sub> 1 T-cellsMario L Marques-Piubelli, Riyad N H Seervai, Kumaran M Mudaliar, et al.
Pageof 30

Showing results (241-250 of 292) with videos related to

Sort By:
Pageof 30
Histopathology|December 17, 2008
Annexin A1 subcellular expression in laryngeal squamous cell carcinomaV A F Alves, S Nonogaki, P M Cury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLCPedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune functionM Choi, H Kadara, J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2018
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-upH Kadara, M Choi, J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-upH Kadara, M Choi, J Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2020
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to PembrolizumabEmily Z Keung, Melissa Burgess, Ruth Salazar, et al.
Vox Sanguinis|November 25, 2003
Current status of immunoprophylaxis with anti-D immunoglobinC P Engelfriet, H W Reesink, W J Judd, et al.
Nature Communications|May 10, 2023
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinomaJose A Karam, Pavlos Msaouel, Cara L Haymaker, et al.
Med (New York, N.Y.)|August 16, 2024
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trialJeffrey A How, Minghao Dang, Sanghoon Lee, et al.
Journal of Cutaneous Pathology|May 7, 2023
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T<sub>H</sub> 1 T-cellsMario L Marques-Piubelli, Riyad N H Seervai, Kumaran M Mudaliar, et al.
Pageof 30